Viking Therapeutics became famous in the biotech world last year after announcing positive phase 2 results for VK2735, an ...

DelveInsight's analysis forecasts liver fibrosis market growth due to the introduction of emerging therapies, expecting an increase in market ...

Bonus Apr 19, 2024 Apr 20, 2024 Feb 29, 2024 Bonus Ratio: 3 share(s) for every 1 shares held Rights Feb 02, 2023 Feb 02, 2023 Aug 25, 2022 Rights ratio: 6 share for every 1 held at a price of Rs 20.0 ...

J B Chemicals & Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Export Incentives, Sale of services and Scrap for the year ending 31-Mar-2023.For ...